bebtelovimab

Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants
NEWS

Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants

ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already licensed by the Meals and Drug Administration for…
Back to top button
close